In Brief: FDA fiscal 1997 budget
This article was originally published in The Tan Sheet
Executive Summary
FDA fiscal 1997 budget: OTC and Rx drugs would receive $273.9 mil. under House Appropriations/agriculture subcommittee bill, unchanged from the Administration's FY 1997 budget proposal. The subcommittee marked up its agriculture appropriations bill, which includes FDA funding, May 30. Under the measure, funding for FDA's foods programs would remain flat at $221.6 mil. -- a $3.8 mil. reduction from the president's request. Overall FDA funding of $920.9 is recommended by the House subcommittee, marking a compromise between the Administration's $924.7 mil. proposal and the $917.7 mil. fiscal 1996 level. Unauthorized user fees for foods and medical devices, which totaled $39 mil. in the president's request, are dropped in the House measure, although the bill retains Rx drug and mammography clinics user fees. During the markup, subcommittee member Rep. Jim Walsh (R-N.Y.) suggested adding report language requiring FDA to meet its user fee deadlines. The House Appropriations Committee is expected to mark up the bill on June 6...